|
WO2021007330A1
|
|
Cerdulatinib-containing topical skin pharmaceutical compositions and uses thereof
|
|
US2020147000A1
|
|
Use of tapinarof for the treatment of chronic plaque psoriasis
|
|
US2020147001A1
|
|
Use of tapinarof for the treatment of atopic dermatitis
|
|
CA3101064A1
|
|
Topical formulations of dgat1 inhibitors and their methods of use
|
|
BR112020013976A2
|
|
PHARMACEUTICAL COMPOSITIONS FOR SKIN TOPICS CONTAINING CERDULATINIBE AND USES OF THE SAME
|
|
WO2019113475A1
|
|
Topical ointment formulations and their use in treating skin conditions
|
|
KR20200097297A
|
|
Topical ointment formulations of PDE-4 inhibitors and their use in the treatment of skin conditions
|
|
CN111511357A
|
|
Process for the preparation of talofu
|
|
CN109475555A
|
|
The local preparation and their application method of PDE-4 inhibitor
|
